Intra-articular zoledronic acid in a rat osteoarthritis model: significant reduced synovitis may indicate chondroprotective effect

Knee Surgery, Sports Traumatology, Arthroscopy

Volumn 23, Issue 5, 2015, Pages 1410-1418

  Cınar, B Murat ^a   Ozkoc, Gurkan ^a   Bolat, Filiz ^a   Karaeminogullari, Oguz ^b   Sezgin, Nurzen ^a   Tandogan, Reha N ^c  

^a BASKENT UNIVERSITY   (Turkey)

^b BAYINDIR HOSPITAL   (Turkey)

^c Department of Orthopedics and Traumatology   (Turkey)

Author keywords

Intra articular; Osteoarthritis; Zoledronic acid

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE; ZOLEDRONIC ACID;

ANIMAL; ARTICULAR CARTILAGE; CARTILAGE CELL; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; INTRAARTICULAR DRUG ADMINISTRATION; MALE; OSTEOARTHRITIS, KNEE; PATHOLOGY; RAT; SYNOVITIS; SYNOVIUM; WISTAR RAT;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; CARTILAGE, ARTICULAR; CHONDROCYTES; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; IMIDAZOLES; INJECTIONS, INTRA-ARTICULAR; MALE; OSTEOARTHRITIS, KNEE; RATS; RATS, WISTAR; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 84896427759     PISSN: 09422056     EISSN: 14337347     Source Type: Journal    
DOI: 10.1007/s00167-014-2955-z     Document Type: Article

References (36)

1. Andreollo NA, Santos EF, Araujo MR, Lopes LR (2012) Rat’s age versus human’s age: what is the relationship? ABCD Arg Bras Cir Dig 25(1):49–51
2. Bendele AM (2001) Animal models of osteoarthritis. J Musculoskel Neuron Interact 1(4):363–376
3. Biswal S, Hastie T, Andriacchi TP, Bergman GA, Dillingman MF, Lang P (2002) Risk factors for progressive cartilage loss in the knee: a longitudinal magnetic resonance imaging study in forty-three patients. Arthritis Rheum 46(11):2884–2892
4. Bobinac D, Spanjol J, Zoricic S, Maric I (2003) Changes in articular cartilage and subchondral bone histomorphometry in osteoarthritic knee joints in humans. Bone 32:284–290
5. Carbone LD, Nevitt MC, Wildy K, Barrow KD et al (2004) The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 50(11):3516–3525
6. Ceponis A, Waris E, Mönkkönen J, Laasonen L, Hyttinen M (2001) Effects of low-dose, noncytotoxic, intraarticular liposomal clodronate on development of erosion and proteoglycan loss in established antigen- induced arthritis in rabbits. Arthritis Rheum 44(8):1908–1916
7. Derenne S, Amiot M, Barille S, Collette M, Robillard N, Berthaud P, Harousseau JL, Bataille R (1999) Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment. J Bone Miner Res 14:2048–2056
8. Doschak MR, Wohl GR, Hanley DA, Bray RC, Zernicke RF (2004) Antiresorptive therapy conserves some periarticular bone and ligament mechanical properties after anterior cruciate ligament disruption in the rabbit knee. J Orthop Res 22:942–948
9. Garnero P, Delmas PD (2003) Biomarkers in osteoarthritis. Curr Opin Rheumatol 15:641–646
10. Goldring MB (2000) The role of the chondrocyte in osteoarthritis. Arthritis Rheum 43:1916–1926
11. Hasegawa J, Nagashima M, Yamamoto M, Nishijima T, Katsumata S, Yoshino S (2003) Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis. J Rheumatol 30:474–479
12. Hayami T, Pickarski M, Wesolowski GA, Mclane J, Bone A, Destefano J, Rodan GA, Duong LT (2004) The role of subchondral bone remodeling in osteoarthritis. Arthritis Rheum 50(4):1193–1206
13. Hayami T, Pickarski M, Ya Zhuo, Wesolowski GA, Rodan GA, Le Duong T (2006) Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 38:234–243
14. Helmark IC, Mikkelsen UR, Krogsgaard MR, Belhage B, Petersen MCH, Langberg H, Kjaer M (2010) Early osteoarthritis and microdialysis: a novel in vivo approach for measurements of biochemical markers in the perisynovium and intraarticularly. Knee Surg Sports Traumatol Arthrosc 18:1617–1623
15. Kraus VB, Burnett B, Coindreau J, Cottrell S, Eyre D et al (2011) Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthr Cartlil 19(5):515–542
16. Larsson E, Müssener A, Heinegard D, Klareskog L, Saxne T (1997) Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. Br J Rheumatol 36:1258–1261
17. Liu W, Burton-Wurster N, Glant TT et al (2003) Spontaneous and experimental osteoarthritis in dog: similarities and differences in proteoglycan levels. J Orthop Res 21(4):730–737
18. Lohmander LS (2000) What can we do about osteoarthritis? Arthritis Res 2:95–100
19. Mankin HJ, Dorfman H, Lippiello L, Zarins A (1971) Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg [Am] 53:523–537
20. Matsuo A, Shuto T, Hirata G, Satoh H, Matsumoto Y, Zhao H, Iwamoto Y (2003) Antiinflammatory and chondroprotective effects of the aminobisphosphonate incadronate (YM175) in adjuvant induced arthritis. J Rheumatol 30:1280–1290
21. McDaniel WJ, Dameron TB (1983) The untreated anterior cruciate ligament rupture. Clin Orthop Relat Res 172:158–163
22. Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Canser 104(1):83–93
23. Moskowitz RW (1992) Experimental models of osteoarthritis. In: Moskowitz RW (ed) osteoarthritis, 2nd edn. Saunders, Philadelphia, pp 213–232
24. Niedhart M, Hauser N, Paulsson M, Dicesare PE, Michel BA, Hauselmann HJ (1997) Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. J Rheumatol [Br] 36:1151–1160
25. Otto S, Sotlar K, Ehrenfeld M, Pautke C (2011) Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: a case report. J Med Case Rep 23(5):477
26. Pelletier JP, Mineau F, Faure MP, Martel-Pelletier J (1990) Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum 33(10):1466–1476
27. Podworny NV, Kandel RA, Renlund RC, Grynpas MD (1999) Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis. J Rheumatol 26:1972–1982
28. Radin EL, Rose RM (1986) Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Relat Res 213:34–40
29. Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P et al (2002) Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346:653–661
30. Rooney M, Condell D, Quinlan W, Daly L, Whelan A, Feighery C, Bresnihan B (1988) Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum 31:956–963
31. Rossini M, Viapiana O, Ramonda R, Bianchi G, Olivieri I et al (2009) Intra-articular clodronate for the treatment of knee osteoarthritis: doe ranging study versus hyalunaric acid. Rheumatology 48:773–778
32. Rutgers M, van Pelt MJ, Dhert WJ, Creemers LB, Saris DB (2010) Evaluation of histological scoring systems for tissue-engineered, repaired and osteoarthritic cartilage. Osteoarthr Cartlil 18(1):12–23
33. Strassle BW, Mark L, Leventhal L, Piesla MJ, Jian LI, Kennedy JD, Glasson SS, Whiteside GT (2010) Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease. Osteoarthr Cartlil 18:1319–1328
34. Tandoğan RN, Taşer O, Kayaalp A, Taşkıran E, Pınar H, Alparslan B, Alturfan A (2004) Analysis of meniscal and chondral lesions accompanying anterior cruciate ligament tears: relationship with age, time from injury, and level of sport. Knee Surg Sports Traumatol Arthrosc 12:262–270
35. Teronen O, Konttinen YT, Lindqvist C, Salo T, Ingman T, Lauhio A, Ding Y, Santavirta S, Valleala H, Sorsa T (1997) Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate). Calcif Tissue Int 61:59–61
36. Van Offel JF, Schuerwegh AJ, Bridts CH, Stevens WJ, De Clerck LS (2002) Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes. Ann Rheum Dis 61:925–928